Accuray reported $170.24M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Edwards Lifesciences USD 600M 105.4M Mar/2026
Inogen USD 0 0 Jun/2022
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Surmodics USD 29.55M 111K Sep/2024
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Trinity Biotech USD 100.76M 7.05M Dec/2024